Vaccine Hesitancy Intervention--Provider (VHIP) (VHIP)
|ClinicalTrials.gov Identifier: NCT01667354|
Recruitment Status : Completed
First Posted : August 17, 2012
Last Update Posted : October 13, 2017
|Condition or disease||Intervention/treatment|
|Childhood Vaccination||Behavioral: Academic Detailing|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||491 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Vaccine Hesitancy Intervention--Provider (VHIP)|
|Study Start Date :||February 2012|
|Primary Completion Date :||October 2013|
|Study Completion Date :||April 2014|
Experimental: Intervention Clinics
Providers in intervention clinics will receive a training followed by telephone coaching and follow-up visits for six months.
Behavioral: Academic Detailing
The intervention design is based on "academic detailing," an effective method of changing physician behavior. The aim of the training is effective communication with parents who are hesitant about childhood vaccinations.
No Intervention: Control Clinics
Control clinics will receive all intervention materials at the completion of the study.
- Parental Vaccine Hesitancy Measure [ Time Frame: Change from Baseline in Parental Hesitancy at 6 months ]The investigators will contact mothers of newborns in study practices and conduct a telephone survey at two time points: baseline and 6 months. Surveys will assess parental hesitancy, parental trust in provider, and other covariates such as perceived social norms, other sources of information about vaccines, and demographic information.
- Physician Self Efficacy Measure [ Time Frame: Change from Baseline in Physician Attitudes at 6 months ]Assessed via self-administered surveys of providers in all participating clinics at baseline and 6-months. The investigators will measure physician attitudes, perceived norms, intentions to change behavior, practice characteristics, and physician demographics.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01667354
|United States, Washington|
|Group Health Research Institute|
|Seattle, Washington, United States, 98101|
|Principal Investigator:||David Grossman, MD, MPH||Kaiser Permanente|